Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
ABAT	GABAT	ENSG00000183044	"4-aminobutyrate aminotransferase"	P80404	16	8674565-8784575	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Neurotransmitter degradation"	"Aminotransferase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 53.3;liver: 136.5;pancreas: 54.2"	"Cell type enhanced"	"Detected in many"	19	"Hepatocytes: 234.8;Proximal tubular cells: 72.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 45.3;MCF7: 29.1;RH-30: 25.6;T-47d: 15.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041528, HPA041690"	Enhanced	Supported	Supported	Mitochondria		No	No		1500000	Mitochondria		"HPA041528: AB_10795690, HPA041690: AB_10794674"	"unprognostic (1.77e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.05e-1)"	"prognostic favorable (5.36e-5)"	"prognostic favorable (5.93e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.04e-1)"	"prognostic favorable (5.44e-8)"	"unprognostic (2.10e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.50e-2)"	2.1	12.6	26.1	2.7	39.3	1.7	3.2	19.9	43.3	2.2	5.2	10.9	0.1	17.5	2.1	5.0	3.0	2.8	2.7	6.2	20.4	30.9	53.3	136.5	2.8	2.8	24.5	26.1	5.3	54.2	4.0	22.1	2.3	14.3	9.9	4.2	2.6	2.6	2.5	1.4	2.1	8.4	2.1	14.1	2.5	3.9	6.3	11.8	1.0	12.7	0.4	3.3	6.4	1.1	2.2	1.9	8.8	5.8	1.6	2.5	1.8	0.2	0.0	12.1	6.9	1.9	0.7	0.5	1.4	0.8	0.7	0.2	4.5	0.3	1.4	0.5	0.8	0.4	3.1	0.8	2.8	0.9	0.8	0.6	2.0	0.0	45.3	3.1	0.4	3.1	2.5	1.3	1.2	0.5	0.3	0.2	3.9	0.3	1.0	0.2	29.1	0.7	0.2	1.0	8.5	0.1	3.5	25.6	0.6	0.4	7.2	1.9	5.8	0.7	0.4	0.0	2.5	15.9	1.2	0.2	0.2	2.0	0.9	0.0	1.1	0.1	0.3	0.3	2.1	1.4	1.1	3.1	4.1	2.5	3.6	1.1	0.8	1.7	1.7	1.9	2.2	1.1	1.8	8.8	1.6	5.8	0.3	1.6	1.8	26.1	39.3	19.9	35.1	20.4	30.9	24.5	26.1	14.3	11.8	0.0	5.8	12.2	3.3	1.3	16.6	8.9	15.3	2.7	7.9	1.8	3.9	1.2	19.9	1.2	8.3	1.4	10.3	0.0	5.5	1.2	2.1	9.6	1.1	234.8	4.3	33.4	15.0	5.5	9.1	6.0	3.4	5.4	1.7	0.0	4.9	48.7	6.3	6.5	4.2	72.0	6.0	0.0	2.5	1.5	0.9	0.5	1.1	7.2	6.8	4.2
ALDH1B1	"ALDH5, ALDHX"	ENSG00000137124	"Aldehyde dehydrogenase 1 family member B1"	P30837	9	38392664-38398661	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 113.9"	"Group enriched"	"Detected in many"	5	"Cholangiocytes: 117.2;Ductal cells: 60.1;Extravillous trophoblasts: 40.0;Hepatocytes: 113.4;Proximal tubular cells: 118.8;Undifferentiated cells: 68.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 55.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021037, HPA077080"	Enhanced		Supported	Nucleoplasm,Vesicles,Mitochondria,Cytosol		NA	NA		210000	Mitochondria	"Nucleoplasm, Vesicles, Cytosol"	"HPA021037: AB_1844724, HPA077080: "	"unprognostic (4.16e-1)"	"unprognostic (1.98e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.55e-3)"	"unprognostic (2.47e-2)"	"unprognostic (4.48e-3)"	"unprognostic (2.84e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (2.89e-2)"	7.4	4.9	2.1	16.8	2.1	0.6	5.4	1.1	5.4	5.8	25.4	1.7	6.1	7.0	27.3	10.7	21.6	16.7	30.8	11.6	3.1	2.0	18.0	55.2	3.5	5.9	2.4	2.0	12.2	14.6	1.4	1.4	1.6	3.0	22.7	11.5	5.2	5.9	18.2	19.4	3.0	11.2	113.9	2.7	2.8	15.8	7.8	1.7	1.6	6.3	7.0	2.0	54.5	8.3	5.9	9.4	1.2	10.5	7.5	10.2	5.1	21.5	20.1	6.2	9.9	8.8	10.5	5.0	10.3	5.2	8.7	9.0	13.4	4.2	13.6	6.2	14.5	13.2	3.0	20.4	21.9	8.7	15.2	8.8	6.7	14.8	39.8	6.4	10.7	7.6	12.5	4.8	7.1	6.2	17.9	8.3	3.3	19.4	13.4	13.2	8.2	0.0	4.3	18.4	55.5	9.0	4.4	37.6	10.4	7.8	9.7	13.6	6.3	7.9	5.2	6.0	6.8	4.9	8.4	5.6	10.1	16.7	8.4	12.9	2.0	3.9	5.4	5.2	11.0	6.8	0.2	4.2	0.2	7.3	9.1	10.2	5.9	7.0	6.6	9.4	3.1	5.8	6.8	1.2	7.5	10.5	1.3	4.8	5.1	2.1	2.1	1.1	5.4	3.1	2.0	2.4	2.0	3.0	1.7	8.9	1.7	3.6	3.8	0.9	1.3	5.6	117.2	0.0	3.4	15.7	2.0	1.3	14.9	60.1	0.5	3.8	7.0	0.0	5.9	40.0	6.2	2.9	9.2	113.4	6.5	0.0	15.0	9.8	3.8	1.3	6.1	4.0	0.0	7.2	16.9	1.3	14.2	3.5	6.3	118.8	0.3	0.0	9.5	0.3	0.6	0.9	1.5	2.9	68.9	2.6
ALDH2		ENSG00000111275	"Aldehyde dehydrogenase 2 family (mitochondrial)"	P05091	12	111766887-111817529	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 279.7"	"Cell type enhanced"	"Detected in all"	9	"Hepatocytes: 770.8;monocytes: 1397.7;Proximal tubular cells: 645.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 45.8;myeloid DC: 46.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 46.6;monocytes: 45.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 25.4;HHSteC: 28.4;OE19: 41.9;SK-BR-3: 57.1;THP-1: 25.4"									HPA051065	Approved					NA	NA		1400000			"HPA051065: AB_2681332"	"unprognostic (9.22e-3)"	"unprognostic (1.20e-2)"	"unprognostic (4.14e-3)"	"prognostic favorable (2.63e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-3)"	"prognostic favorable (3.95e-7)"	"unprognostic (5.62e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.51e-1)"	"prognostic favorable (5.24e-6)"	"unprognostic (9.70e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (7.71e-4)"	88.9	34.0	42.1	17.0	44.6	9.9	39.6	14.3	30.9	10.4	25.3	17.5	16.8	25.6	9.0	11.6	26.4	10.3	28.5	45.0	30.9	24.2	59.0	279.7	38.1	13.3	34.1	32.6	16.1	14.0	2.2	7.6	4.0	30.6	13.5	26.2	13.1	17.9	30.7	40.1	43.5	25.5	29.4	26.6	8.0	34.9	9.5	23.8	3.3	12.0	28.1	18.2	17.0	22.9	1.4	46.6	10.8	45.8	0.7	0.2	21.7	2.4	3.6	5.3	9.1	25.4	3.8	17.4	2.6	4.7	1.2	0.9	6.5	3.4	0.1	13.0	5.7	3.4	4.5	0.0	1.3	0.7	0.1	1.7	0.2	2.3	17.6	28.4	0.2	0.2	6.9	6.5	4.2	0.1	5.1	7.6	0.2	4.8	0.8	1.1	0.1	0.2	6.3	7.0	41.9	0.6	0.1	0.1	0.5	8.8	0.1	2.1	6.6	6.4	57.1	0.0	10.1	5.7	25.4	0.3	0.1	4.8	0.1	0.1	1.5	0.8	6.9	6.3	0.2	0.1	0.9	45.8	10.8	0.1	20.1	0.2	1.4	0.0	0.1	46.6	1.2	0.1	0.1	2.3	0.7	5.0	15.5	0.1	21.7	42.1	44.6	14.3	30.9	30.9	24.2	34.1	32.6	30.6	23.8	137.0	197.2	37.4	126.5	53.2	67.9	333.7	140.1	95.0	178.6	62.8	17.7	50.7	338.2	110.9	3.4	72.6	272.6	70.0	195.0	101.4	59.3	72.9	29.0	770.8	132.7	33.4	53.0	106.2	211.9	7.0	73.9	169.3	33.7	1397.7	184.2	107.6	110.7	325.4	140.0	645.3	34.9	45.3	77.3	2.7	3.2	109.0	35.2	13.8	218.4	82.3
ALDH3A2	"ALDH10, FALDH, SLS"	ENSG00000072210	"Aldehyde dehydrogenase 3 family member A2"	P51648	17	19648136-19677598	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation, Ichthyosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 35.6;OE19: 66.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014769, CAB020692"	Approved					NA	NA					"CAB020692: , HPA014769: AB_1844728"	"unprognostic (1.42e-1)"	"unprognostic (7.62e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.59e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.93e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.63e-1)"	"prognostic favorable (3.85e-8)"	"unprognostic (4.12e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.26e-1)"	22.3	66.4	8.5	9.0	24.6	2.8	10.0	8.8	12.8	13.7	15.9	17.5	7.5	15.6	13.5	19.2	39.6	10.7	26.4	12.5	9.5	6.5	52.5	88.6	17.7	4.3	11.1	10.3	13.5	24.4	10.1	14.9	3.1	14.4	20.7	11.1	16.2	26.0	10.0	18.5	57.1	26.6	10.5	10.2	8.0	18.3	9.8	15.4	4.5	27.3	27.9	22.5	9.8	17.0	3.9	14.3	11.6	14.2	8.6	6.4	5.7	5.7	35.6	3.6	8.9	17.0	14.3	2.5	1.7	4.3	3.4	3.8	11.1	9.2	1.8	4.1	7.0	5.9	12.7	14.0	17.1	2.4	7.9	6.1	0.9	18.7	27.2	3.2	4.2	0.4	7.9	24.3	3.1	1.9	8.9	6.7	4.8	0.2	0.0	8.5	7.7	0.1	5.2	8.5	66.4	19.5	4.1	10.2	5.4	3.9	18.0	6.9	4.9	15.5	6.0	4.9	22.9	10.4	3.9	7.9	2.2	4.0	5.7	5.3	2.4	6.0	2.5	10.5	0.0	7.0	0.0	14.2	11.6	4.2	12.6	6.4	3.9	4.3	3.7	14.3	3.0	4.9	3.4	0.7	8.6	13.7	0.2	5.8	5.7	8.5	24.6	8.8	12.8	9.5	6.5	11.1	10.3	14.4	15.4	163.8	69.7	11.9	106.4	50.7	13.8	39.2	104.4	69.6	113.7	31.4	11.8	10.6	36.5	84.4	78.7	15.8	49.7	0.0	45.0	3.4	27.7	87.9	27.8	102.6	23.4	6.4	15.5	14.1	16.7	14.7	51.8	24.2	6.8	21.6	25.0	98.7	45.1	28.1	75.7	88.8	20.1	12.9	14.6	10.4	22.6	78.9	1.1	13.8	36.8	28.6
ALDH4A1	"ALDH4, P5CDh"	ENSG00000159423	"Aldehyde dehydrogenase 4 family member A1"	P30038	1	18871430-18902781	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Proline metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 73.7;liver: 92.6"	"Cell type enhanced"	"Detected in many"	16	"Hepatocytes: 313.9;Proximal tubular cells: 167.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 72.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Hep G2: 34.6;SK-BR-3: 35.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004645, HPA006401, HPA072759"	Enhanced		Supported	Mitochondria		NA	NA		40000	Mitochondria		"CAB004645: AB_425775, HPA006401: AB_1844731, HPA072759: "	"unprognostic (1.17e-1)"	"prognostic favorable (5.06e-4)"	"unprognostic (1.38e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.15e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.27e-3)"	"unprognostic (9.41e-3)"	"unprognostic (3.83e-1)"	"unprognostic (2.69e-3)"	"unprognostic (9.34e-2)"	22.9	4.1	14.4	2.0	18.0	4.6	6.6	3.1	16.8	3.8	2.4	8.6	18.9	1.3	2.5	5.2	11.4	2.7	3.0	12.6	8.6	7.1	73.7	92.6	2.4	1.7	15.9	11.2	2.9	2.2	9.4	2.4	8.3	8.5	12.1	1.6	9.7	2.4	12.1	25.6	8.0	1.3	3.3	2.7	2.1	3.4	1.4	6.6	2.8	3.0	8.9	2.9	8.3	3.6	1.5	7.2	2.6	5.6	0.3	1.4	2.2	5.1	8.0	4.1	12.1	17.4	2.6	10.0	4.9	3.0	5.1	4.1	5.8	3.8	3.4	6.6	6.4	2.4	13.8	6.9	14.7	1.9	1.9	6.1	1.9	1.9	34.6	5.5	1.7	6.2	6.7	8.2	2.8	2.8	3.8	5.7	5.8	7.7	2.5	3.4	13.2	1.7	8.3	2.0	10.6	4.1	10.7	3.4	4.0	5.3	13.0	8.1	3.1	8.7	35.8	6.4	6.5	16.3	2.6	4.7	4.4	5.8	5.3	1.7	2.8	6.6	1.0	1.6	13.5	5.8	0.0	4.1	2.6	1.1	5.6	0.9	1.5	0.7	1.4	7.2	1.1	0.3	0.9	0.6	0.3	3.1	2.4	1.0	2.2	14.4	18.0	3.1	16.8	8.6	7.1	15.9	11.2	8.5	6.6	0.0	3.2	7.2	14.0	6.6	3.1	18.5	38.2	1.4	0.0	43.6	9.8	61.1	39.7	5.6	0.4	2.7	0.4	0.0	0.8	7.2	2.3	9.5	4.6	313.9	11.9	19.1	2.4	16.5	14.0	0.4	1.1	1.4	3.3	17.2	2.9	10.8	2.9	1.5	2.5	167.5	4.2	6.5	4.3	2.1	3.6	4.6	72.4	2.2	3.3	9.7
ALDH7A1	"ATQ1, EPD, PDE"	ENSG00000164904	"Aldehyde dehydrogenase 7 family member A1"	P49419	5	126531200-126595418	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 64.4"	"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 364.8;Proximal tubular cells: 241.4;Syncytiotrophoblasts: 185.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 9.7"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 9.7"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 61.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023296, HPA053675"	Enhanced		Supported	Mitochondria,Cytosol		Yes	No		140000	Mitochondria	Cytosol	"HPA023296: AB_1844738, HPA053675: "	"unprognostic (1.37e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.58e-3)"	"unprognostic (9.49e-3)"	"unprognostic (7.61e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (3.08e-4)"	"unprognostic (1.51e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.10e-3)"	"unprognostic (4.93e-2)"	9.0	14.2	46.0	3.4	39.1	0.8	18.8	11.0	22.5	14.0	11.5	23.1	7.2	9.5	10.5	7.5	13.5	11.9	7.8	10.8	35.0	17.3	46.5	64.4	6.4	3.1	28.7	18.5	27.6	10.8	17.7	5.9	17.7	16.9	17.6	11.2	13.7	15.0	12.2	4.5	11.9	8.1	9.8	20.2	2.8	9.0	4.9	28.4	4.0	19.4	10.1	7.4	7.2	7.1	1.3	9.7	0.7	0.3	0.1	1.8	0.6	15.0	10.0	28.3	46.8	23.5	14.0	36.1	18.1	22.4	21.1	27.2	28.0	14.5	0.0	18.5	14.1	8.8	11.3	8.8	61.1	19.4	0.0	10.6	2.9	14.9	23.8	11.5	0.0	0.0	17.1	14.4	16.4	11.8	15.6	16.8	0.0	0.0	0.0	18.5	9.9	0.6	0.0	19.1	11.1	8.5	9.0	32.1	0.0	20.0	11.5	9.6	11.5	0.0	10.0	10.5	22.7	18.0	0.6	20.4	6.1	18.9	7.0	12.4	0.0	0.0	0.0	3.3	0.0	9.8	0.7	0.3	0.1	0.2	0.0	0.3	1.3	0.3	0.2	2.7	1.1	1.8	1.0	0.3	0.1	0.0	9.7	0.1	0.6	46.0	39.1	11.0	22.5	35.0	17.3	28.7	18.5	16.9	28.4	14.9	24.0	11.8	48.6	23.0	22.4	35.5	25.5	20.1	33.0	40.1	21.6	364.8	64.6	31.9	24.9	14.7	17.8	0.0	12.1	88.6	30.8	28.6	6.9	69.5	42.5	23.8	20.8	20.9	9.4	29.5	23.6	7.4	52.3	12.6	22.1	96.8	15.1	8.6	35.0	241.4	12.2	19.4	17.3	1.0	3.1	14.1	185.9	2.5	43.7	34.8
ALDH9A1	"ALDH4, ALDH7, ALDH9, E3"	ENSG00000143149	"Aldehyde dehydrogenase 9 family member A1"	P49189	1	165662216-165698863	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Muller glia cells: 289.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006077, HPA010873"	Approved		Approved	Cytosol	"Intracellular and membrane"	NA	NA		1100000	Cytosol		"HPA006077: , HPA010873: AB_1078126"	"unprognostic (2.24e-1)"	"unprognostic (3.16e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.14e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.83e-1)"	"prognostic favorable (4.56e-4)"	"unprognostic (5.51e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.15e-1)"	39.1	52.7	30.8	17.4	25.4	7.7	39.6	16.2	26.6	20.3	18.0	22.7	17.1	19.5	15.5	35.5	47.0	18.8	22.2	22.2	24.8	21.1	50.5	73.5	20.7	20.4	23.7	18.4	20.6	17.8	31.2	19.2	14.1	22.8	24.6	18.7	27.2	52.2	23.2	29.9	22.6	23.9	19.2	21.9	18.8	14.7	37.3	21.5	12.4	45.1	24.2	27.9	18.5	19.1	29.6	20.2	29.4	24.5	23.1	39.0	24.4	17.0	16.7	15.6	14.0	49.9	44.0	13.1	22.6	32.1	22.8	19.8	10.3	12.8	0.0	21.7	20.2	11.2	13.5	12.6	22.1	27.0	7.9	16.0	10.9	12.0	11.2	25.7	17.0	11.6	28.2	11.2	24.1	20.2	31.6	19.7	14.5	17.2	15.4	35.4	10.2	11.3	17.6	22.7	44.9	20.5	9.7	19.8	22.8	29.6	16.2	18.6	12.8	16.1	18.2	20.7	22.1	34.6	25.9	19.4	13.8	13.5	16.7	11.4	14.4	18.7	17.0	15.5	16.3	13.2	26.8	20.3	28.1	28.3	21.5	30.1	29.6	27.7	30.6	20.2	26.0	28.1	32.0	29.4	23.1	24.5	12.6	39.0	24.4	30.8	25.4	16.2	26.6	24.8	21.1	23.7	18.4	22.8	21.5	14.9	37.5	27.9	34.1	29.0	24.6	38.9	48.4	69.6	30.7	48.8	21.6	42.9	82.9	36.4	32.5	37.9	44.4	23.3	32.5	64.2	46.7	49.5	36.9	114.6	53.7	12.7	53.6	52.8	58.2	28.9	88.3	37.5	54.0	19.8	52.5	289.8	28.8	31.6	108.5	141.7	26.8	25.8	36.0	33.8	46.2	45.4	31.9	38.9	58.1	23.5
AOC1	"ABP1, DAO"	ENSG00000002726	"Amine oxidase, copper containing 1"	P19801	7	150824627-150861504	"Enzymes, Predicted secreted proteins"		"Heparin-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 108.6;placenta: 240.4"	"Cell type enhanced"	"Detected in many"	19	"Collecting duct cells: 258.2;Enterocytes: 648.3;Paneth cells: 375.2"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 61.3;endometrial cancer: 39.1;pancreatic cancer: 26.9;renal cancer: 69.4;stomach cancer: 43.2"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	10	"eosinophil: 20.3"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 20.3"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 16.4;HaCaT: 5.0;NB-4: 5.0;RPMI-8226: 6.0;THP-1: 21.4"					"Not detected"	"Not detected"			"HPA031032, HPA031033"	Approved				"Secreted in other tissues"	NA	NA		800000			"HPA031032: AB_10670150, HPA031033: AB_10669670"	"unprognostic (1.73e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.84e-2)"	"unprognostic (6.31e-3)"	"unprognostic (8.31e-3)"	"unprognostic (9.07e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.11e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (5.32e-3)"	"unprognostic (3.62e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.64e-1)"	0.3	0.3	0.3	6.7	0.3	0.0	0.3	0.3	0.3	0.9	68.3	0.2	1.2	30.2	0.3	3.9	1.7	0.3	4.4	0.3	0.3	0.3	37.9	1.5	0.3	0.6	0.3	0.1	0.3	0.6	0.0	0.3	240.4	0.1	1.3	15.5	0.1	0.4	0.2	0.3	0.8	108.6	0.2	0.3	0.4	2.7	1.8	0.1	0.7	0.3	0.1	1.0	0.4	0.4	0.0	1.0	20.3	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.8	0.1	0.0	0.0	0.0	2.5	16.4	0.0	2.2	0.0	1.4	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.3	0.1	5.0	0.2	1.5	0.0	0.0	0.0	6.0	0.2	0.1	1.8	2.1	0.0	0.7	0.0	0.3	0.6	21.4	0.5	0.2	0.1	0.5	0.0	0.2	0.1	0.1	0.1	0.8	0.0	0.1	0.1	20.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.1	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.3	0.0	0.0	1.2	258.2	0.0	1.1	13.3	0.0	5.7	0.0	648.3	0.0	3.0	3.0	0.2	0.9	5.7	0.0	2.8	0.0	41.6	0.0	0.0	8.4	0.0	1.3	0.0	115.4	108.6	0.0	2.2	375.2	0.0	73.1	0.0	0.0	0.1	2.8	0.7	0.1	2.9	0.0	80.4	0.3
AOC2	"DAO2, RAO"	ENSG00000131480	"Amine oxidase, copper containing 2"	O75106	17	42844600-42850707	"Enzymes, Predicted intracellular proteins"	"Catecholamine metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"retina: 133.5"	"Cell type enriched"	"Detected in some"	9	"Early spermatids: 28.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.8"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 4.0"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 4.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 14.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA057779	Uncertain				"Intracellular and membrane"	NA	NA					"HPA057779: "	"unprognostic (3.79e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.10e-4)"	"unprognostic (1.90e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.16e-2)"	"unprognostic (8.27e-3)"	"unprognostic (4.55e-5)"	"unprognostic (3.55e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.63e-2)"	"prognostic favorable (2.47e-4)"	11.6	1.2	0.9	1.3	3.2	1.8	3.1	3.2	1.6	1.5	1.1	0.9	0.9	0.6	1.5	1.2	1.0	1.5	1.5	1.3	1.2	1.8	0.9	3.6	2.2	1.0	0.9	0.9	1.0	1.2	0.8	2.1	0.9	0.9	1.3	0.5	133.5	1.2	1.2	1.4	1.2	1.0	1.3	1.0	1.7	0.7	6.5	0.9	1.0	1.0	0.9	1.2	1.6	0.9	0.1	0.0	4.0	0.0	0.0	0.6	0.0	0.2	2.8	0.6	3.1	14.3	1.4	7.4	0.9	0.9	2.0	2.8	2.2	0.3	1.1	1.4	0.3	0.9	1.2	2.7	0.7	4.1	2.3	7.3	0.4	1.3	2.2	0.9	0.4	2.8	2.2	2.5	1.9	2.9	0.4	0.5	3.8	0.7	2.6	0.6	0.3	0.6	1.1	1.1	0.3	0.9	1.4	2.9	2.3	0.4	4.4	1.0	0.6	0.1	1.0	4.0	6.0	0.5	0.2	0.5	1.9	4.1	2.5	1.2	5.7	5.6	1.1	0.5	2.6	1.0	0.0	0.0	0.8	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.2	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.9	3.2	3.2	1.6	1.2	1.8	0.9	0.9	0.9	0.9	0.0	0.3	0.0	0.5	0.9	0.2	0.3	0.0	0.0	1.2	0.0	2.0	0.1	0.0	0.4	28.8	0.7	0.0	0.0	0.3	0.1	0.2	0.7	0.0	0.8	0.1	0.0	0.0	0.6	0.8	3.3	0.3	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.2	0.6	0.0	0.9	2.1	2.7	1.4	0.0	0.0	0.0	0.5
AOC3	"HPAO, VAP-1, VAP1"	ENSG00000131471	"Amine oxidase, copper containing 3"	Q16853	17	42851184-42858130	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	19	"Peritubular cells: 70.4;Sertoli cells: 116.4;Smooth muscle cells: 56.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	13	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.2"	"Cell line enriched"	"Detected in some"	18	"ASC diff: 85.5"	"Low region specificity"	"Detected in many"							"HPA000980, CAB025797"	Enhanced		Approved	"Golgi apparatus,Cytosol"	"Secreted - unknown location"	NA	NA		240000000	Cytosol	"Golgi apparatus"	"CAB025797: , HPA000980: AB_1078170"	"unprognostic (2.20e-1)"	"unprognostic (4.49e-2)"	"prognostic unfavorable (3.68e-4)"	"unprognostic (2.97e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.95e-1)"	"unprognostic (9.02e-2)"	"prognostic unfavorable (1.79e-5)"	"unprognostic (5.61e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (6.98e-4)"	97.0	11.5	0.4	18.7	1.0	0.0	67.7	0.5	1.3	26.9	44.3	1.0	16.3	3.6	44.7	34.8	36.1	18.5	50.9	12.1	0.4	0.4	5.8	8.3	48.0	7.9	0.5	1.2	23.8	2.4	2.2	1.3	10.8	2.0	36.5	9.4	32.1	8.0	24.7	7.7	5.5	15.0	79.2	0.6	7.5	17.7	16.2	0.3	1.0	6.6	11.6	2.6	75.9	20.9	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	85.5	0.1	1.3	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.2	0.3	1.5	0.1	0.1	4.7	0.2	0.0	0.2	0.9	0.2	0.1	0.2	0.0	0.0	0.5	0.0	0.4	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.2	0.2	0.7	0.0	0.5	0.0	0.1	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.7	0.3	0.1	1.2	1.4	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4	1.0	0.5	1.3	0.4	0.4	0.5	1.2	2.0	0.3	3.0	8.9	0.8	0.0	2.6	0.0	3.2	0.0	1.4	3.4	0.0	0.0	0.1	0.0	0.1	3.8	4.7	0.0	0.0	0.2	0.1	2.6	0.2	1.1	0.0	1.1	0.0	0.0	22.7	3.0	2.1	3.1	0.5	3.3	0.0	0.0	0.4	0.1	0.0	70.4	0.7	0.5	116.4	56.5	0.9	0.7	1.6	0.2	0.0	0.0	0.3
CARNS1	"ATPGD1, KIAA1394"	ENSG00000172508	"Carnosine synthase 1"	A5YM72	11	67414968-67425607	"Enzymes, Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	14	"brain: 88.7;skeletal muscle: 64.8"	"Cell type enhanced"	"Detected in some"	21	"Alveolar cells type 1: 3.0;Cardiomyocytes: 11.7;Intestinal endocrine cells: 2.9"	"Group enriched"	"Detected in many"	5	"glioma: 4.1;thyroid cancer: 10.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	20	"B-cells: 1.9;NK-cells: 1.3;T-cells: 3.2"	"Cell line enriched"	"Detected in some"	12	"RPMI-8226: 13.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA038569	Enhanced				"Intracellular and membrane"	NA	NA					"HPA038569: AB_2676089"	"unprognostic (1.07e-4)"	"unprognostic (4.33e-3)"	"unprognostic (2.00e-2)"	"unprognostic (6.15e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.28e-2)"	"unprognostic (7.54e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.19e-3)"	"unprognostic (1.00e-1)"	"unprognostic (6.14e-6)"	"unprognostic (3.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.83e-3)"	"unprognostic (8.33e-2)"	2.9	1.3	9.2	1.5	24.3	1.5	1.2	3.0	23.9	1.3	1.4	88.7	0.0	1.5	1.2	2.5	2.0	1.5	1.6	5.3	19.7	10.2	1.2	1.3	1.5	2.1	36.9	14.5	1.4	1.6	2.0	0.4	1.1	30.6	1.8	1.3	0.0	1.3	1.3	64.8	1.3	1.9	1.3	51.1	1.8	2.1	1.1	28.1	0.0	2.3	0.9	1.6	1.1	0.3	1.9	0.1	0.0	0.0	1.3	3.2	0.9	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.0	0.2	0.0	0.2	0.3	0.5	0.7	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.2	0.2	0.8	0.0	0.2	0.0	0.3	0.0	0.2	0.1	0.4	0.1	0.1	1.0	0.6	0.2	0.2	0.0	0.1	0.1	13.1	0.0	0.0	0.1	0.2	0.1	0.8	0.2	0.0	0.1	0.0	0.1	0.1	0.2	0.2	0.0	1.0	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	2.9	0.0	1.4	1.7	1.0	3.1	0.1	1.9	1.3	3.2	0.0	1.3	0.0	0.0	0.7	0.9	9.2	24.3	3.0	22.2	19.7	10.2	36.9	14.5	30.6	28.1	3.0	0.3	1.5	0.1	0.2	0.0	11.7	0.0	1.4	1.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.3	0.0	0.0	0.2	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.4	0.0	0.5	0.0	1.7	0.0	0.2	0.6	0.0	1.3	0.0	0.0
CNDP1	"CN1, CPGL2, HsT2308, MGC10825"	ENSG00000150656	"Carnosine dipeptidase 1"	Q96KN2	18	74534440-74587212	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"brain: 60.3;liver: 41.4"	"Cell type enhanced"	"Detected in some"	24	"Early spermatids: 6.1;Hepatocytes: 26.1;Proximal tubular cells: 14.6"	"Group enriched"	"Detected in some"	10	"glioma: 4.4;liver cancer: 1.0;melanoma: 1.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in single"	69	"U-266/84: 42.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA008933, HPA073283"	Enhanced				"Secreted in brain"	NA	NA		1900000000			"HPA008933: AB_1847033, HPA073283: "	"unprognostic (7.43e-3)"	"unprognostic (6.00e-2)"	"unprognostic (8.55e-3)"	"unprognostic (3.93e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.17e-2)"	"unprognostic (8.04e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.90e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.28e-1)"	1.1	1.2	14.9	1.2	28.2	1.3	1.1	4.5	60.3	1.1	1.1	54.9	0.0	5.7	1.1	2.1	1.1	1.1	1.3	1.1	28.9	15.1	1.9	41.4	1.1	1.2	44.1	12.9	1.1	1.2	1.1	0.1	1.1	50.0	1.2	1.1	0.5	1.1	1.3	2.2	1.1	1.9	1.1	51.1	1.1	1.2	1.4	28.8	0.0	1.3	0.0	1.1	1.1	0.0	0.7	0.7	1.9	0.5	1.0	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	42.2	0.0	0.0	0.0	0.0	1.3	0.5	0.4	0.4	0.2	0.2	0.3	0.3	0.2	0.1	0.7	0.4	0.4	1.9	1.0	0.2	0.7	0.2	0.2	14.9	28.2	4.5	22.5	28.9	15.1	44.1	12.9	50.0	28.8	0.0	0.0	0.0	0.2	0.1	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	6.1	0.0	0.0	0.0	0.2	0.0	0.4	0.4	0.0	26.1	0.1	0.0	0.0	0.6	0.6	1.7	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	14.6	0.6	0.0	0.0	0.9	0.5	0.3	0.0	0.5	0.0	0.2
CNDP2	"CN2, CPGL, FLJ10830, HsT2298, PEPA"	ENSG00000133313	"Carnosine dipeptidase 2"	Q96KP4	18	74495816-74523454	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Proximal tubular cells: 371.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 76.6;RPMI-8226: 98.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026196, HPA036898, HPA036899"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		2400000	"Nucleoplasm, Cytosol"		"CAB026196: , HPA036898: AB_2675370, HPA036899: AB_2675371"	"unprognostic (2.81e-2)"	"unprognostic (9.96e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.57e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.84e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.15e-1)"	"prognostic favorable (3.50e-6)"	"unprognostic (2.37e-3)"	"unprognostic (4.65e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.34e-1)"	19.0	11.5	31.0	19.1	36.0	6.1	16.9	10.4	33.0	39.4	37.6	45.2	27.0	51.3	12.5	35.3	20.4	38.9	25.9	11.6	31.1	26.4	89.0	66.4	22.1	23.0	36.1	24.1	11.4	27.6	15.7	13.7	28.8	27.2	34.7	22.2	14.1	16.9	32.7	7.5	11.8	71.1	10.4	39.4	39.2	27.2	6.5	32.5	10.9	43.9	11.6	21.4	28.4	12.0	29.6	49.0	12.5	44.4	31.4	23.9	30.3	10.2	13.9	10.1	9.5	12.3	7.3	42.4	10.8	10.2	14.8	14.8	8.0	11.1	13.0	13.7	11.7	11.6	15.6	15.3	20.5	10.6	19.4	6.0	12.9	7.0	12.8	18.0	25.2	20.1	11.0	15.8	12.8	23.1	8.4	12.9	15.6	13.6	76.6	9.8	11.5	13.4	12.1	15.2	6.8	8.3	14.6	11.6	98.6	58.2	43.1	11.0	5.8	8.4	60.2	14.4	25.2	25.2	10.4	13.5	15.9	13.5	3.5	7.2	14.3	58.7	17.3	10.8	18.4	13.2	7.8	30.0	12.5	21.8	44.4	23.8	28.9	17.6	20.3	49.0	29.6	19.1	20.7	4.4	31.4	43.1	43.0	23.9	30.3	31.0	36.0	10.4	33.0	31.1	26.4	36.1	24.1	27.2	32.5	68.5	54.2	53.8	35.3	8.1	33.7	22.9	91.7	60.2	38.7	113.4	15.7	128.9	159.2	142.6	2.2	45.9	105.2	0.0	136.1	106.3	20.6	56.1	11.5	102.8	184.6	41.3	62.7	36.8	86.2	3.2	17.3	82.3	16.9	112.8	71.7	80.3	99.7	74.1	15.6	371.2	24.6	12.9	15.9	4.8	7.3	8.4	91.2	36.3	82.5	47.4
ECHS1	SCEH	ENSG00000127884	"Enoyl-CoA hydratase, short chain 1"	P30084	10	133362480-133373689	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Lyase	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 148.2"	"Cell type enhanced"	"Detected in all"	11	"Hepatocytes: 1338.6;Proximal tubular cells: 2021.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003783, HPA021995, HPA022476"	Enhanced		Enhanced	Mitochondria		NA	NA		1500000	Mitochondria		"CAB003783: , HPA021995: AB_1847974, HPA022476: AB_1847975"	"unprognostic (3.68e-1)"	"unprognostic (2.46e-3)"	"unprognostic (9.57e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.51e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (8.57e-5)"	"unprognostic (2.84e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.50e-2)"	36.5	18.7	16.6	9.1	16.6	5.0	15.2	8.2	18.3	8.8	21.8	13.0	34.7	22.8	9.5	14.1	16.5	12.2	17.4	29.8	14.6	11.5	62.1	148.2	6.3	7.8	14.8	10.3	11.6	16.3	9.2	11.0	12.8	11.1	13.9	14.0	11.0	40.2	38.4	35.7	8.8	32.1	9.9	11.9	7.3	11.0	10.2	10.2	3.9	16.2	17.5	13.0	11.2	7.8	39.4	53.7	18.3	45.7	33.5	32.1	44.5	28.9	36.3	19.8	49.3	28.7	18.6	18.1	21.3	28.2	29.8	25.2	79.7	28.1	21.8	18.5	23.9	15.6	27.2	25.7	21.6	21.6	16.7	45.0	21.8	22.0	56.6	24.2	28.1	15.5	20.7	18.7	19.7	25.2	26.5	26.3	15.9	19.6	19.2	28.9	68.6	14.0	55.0	13.8	45.9	43.6	24.2	24.0	11.6	36.8	37.1	12.8	20.3	22.0	36.6	27.7	11.9	28.5	27.2	21.1	13.4	19.5	27.9	28.0	14.4	8.8	24.8	31.9	15.4	11.1	17.0	41.7	18.3	24.9	45.7	32.1	39.4	28.1	27.1	53.7	32.2	28.9	27.9	4.4	33.5	34.3	23.2	26.0	44.5	16.6	16.6	8.2	18.3	14.6	11.5	14.8	10.3	11.1	10.2	41.7	72.4	78.2	79.8	60.7	58.8	224.4	180.9	62.9	56.9	165.7	5.9	406.8	479.1	144.4	24.0	65.0	374.4	46.7	88.5	126.6	74.8	83.9	89.0	1338.6	193.8	42.9	126.4	78.5	88.6	29.7	71.9	72.7	128.2	149.7	152.5	112.9	99.9	252.6	86.3	2021.6	42.1	84.1	76.9	50.6	40.1	66.7	250.1	49.0	276.7	103.8
EHHADH	ECHD	ENSG00000113790	"Enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase"	Q08426	3	185190624-185281990	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Lyase, Multifunctional enzyme, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"kidney: 37.1;liver: 91.2"	"Group enriched"	"Detected in many"	7	"Hepatocytes: 227.5;Proximal tubular cells: 124.0"	"Group enriched"	"Detected in all"	7	"liver cancer: 42.2;renal cancer: 25.4"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"T-47d: 16.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036401, HPA042021"	Enhanced					NA	NA					"HPA036401: AB_10670165, HPA042021: AB_2677801"	"unprognostic (1.20e-1)"	"unprognostic (5.99e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.69e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.89e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.87e-1)"	"prognostic favorable (1.28e-5)"	"unprognostic (1.93e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.80e-1)"	4.1	1.2	1.2	1.7	1.4	0.1	1.5	0.5	1.2	1.7	6.4	0.8	0.4	5.2	1.0	2.0	2.9	0.8	3.0	3.2	1.2	0.9	37.1	91.2	1.9	1.0	1.7	0.7	0.8	2.5	2.7	0.9	1.3	2.1	1.7	2.6	8.3	2.7	0.4	0.7	1.1	9.9	1.0	1.4	1.7	2.4	0.9	0.9	1.4	2.1	1.7	1.2	1.8	1.0	1.5	6.0	0.2	2.2	2.7	2.7	1.1	8.3	3.5	1.0	0.0	5.3	4.5	1.1	4.0	1.2	2.6	3.0	15.2	5.3	0.0	15.9	4.0	1.0	4.1	0.0	3.3	5.5	11.1	3.7	5.9	0.9	15.4	3.5	0.7	0.1	6.4	4.3	2.7	2.4	3.6	3.8	0.0	3.8	4.3	5.0	4.3	0.1	3.5	2.1	3.0	4.4	0.0	7.1	0.3	11.0	4.7	3.2	4.6	7.8	4.6	7.3	9.1	16.8	6.9	1.8	1.7	2.6	1.3	0.3	1.2	3.8	0.3	0.6	2.6	2.8	0.2	2.2	0.0	1.6	2.1	1.0	1.5	1.1	2.4	6.0	0.2	1.6	2.7	0.1	2.7	2.0	2.4	1.4	1.1	1.2	1.4	0.5	1.2	1.2	0.9	1.7	0.7	2.1	0.9	14.9	7.5	13.7	1.5	1.3	0.2	17.9	25.5	4.0	4.5	19.2	3.9	7.2	16.6	2.0	0.1	2.8	13.8	0.0	5.9	2.1	1.5	1.8	0.0	227.5	3.7	0.0	7.5	12.3	12.4	0.0	0.6	1.3	3.3	15.4	11.6	1.7	3.3	8.6	0.4	124.0	0.9	0.0	2.0	3.9	4.1	0.4	1.1	3.2	10.6	1.6
GAD1	GAD	ENSG00000128683	"Glutamate decarboxylase 1"	Q99259	2	170813213-170861151	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Neurotransmitter biosynthesis"	"Decarboxylase, Lyase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 53.9"	"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 9.8;Distal tubular cells: 6.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 10.8;HEL: 34.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"olfactory region: 888.9"	"CAB004415, HPA048871, HPA058412, CAB078176"	Enhanced	Supported	Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane, Cytosol"		"CAB004415: AB_627650, CAB078176: AB_2665792, HPA048871: , HPA058412: AB_2683710"	"unprognostic (1.28e-1)"	"prognostic favorable (7.31e-4)"	"unprognostic (1.87e-2)"	"prognostic favorable (8.61e-4)"	"unprognostic (1.12e-1)"	"unprognostic (3.05e-1)"	"unprognostic (4.97e-7)"	"unprognostic (1.51e-1)"	"unprognostic (7.72e-2)"	"unprognostic (4.27e-4)"	"unprognostic (6.75e-2)"	"unprognostic (9.18e-3)"	"unprognostic (6.90e-5)"	"unprognostic (2.93e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.08e-3)"	1.2	2.0	14.5	0.9	28.1	3.7	1.0	10.6	53.9	1.8	1.0	3.1	0.0	1.0	2.6	5.5	1.2	1.1	1.0	1.0	10.8	24.4	6.0	1.0	1.1	1.1	8.6	17.5	1.1	1.1	9.5	2.8	1.4	6.0	1.8	1.0	1.3	1.0	1.3	0.9	1.0	1.1	1.0	2.6	1.0	1.0	4.0	3.4	0.0	1.1	0.0	1.2	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.4	0.0	3.8	0.0	0.0	0.0	0.2	0.0	1.4	0.9	2.5	3.6	0.0	0.5	0.2	1.7	10.8	1.2	0.3	0.8	1.4	7.4	34.9	3.0	0.1	0.0	0.1	0.6	0.0	3.1	0.0	1.2	0.3	0.0	0.3	9.0	0.1	0.4	0.8	0.0	0.0	4.3	5.2	3.8	0.5	2.6	0.2	4.7	5.0	3.7	1.2	6.6	0.0	1.8	0.3	0.1	0.0	0.0	6.5	0.9	1.3	3.8	0.0	0.0	0.0	6.3	1.7	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	28.1	10.6	36.7	10.8	24.4	8.6	17.5	6.0	3.4	0.0	0.0	0.0	1.4	0.2	3.8	1.1	0.0	0.0	0.0	0.0	9.8	0.0	6.6	4.2	4.3	0.3	0.0	0.0	4.7	0.1	0.2	0.8	0.0	0.0	3.0	4.8	2.9	0.0	0.3	3.6	0.6	0.2	0.0	0.0	0.0	3.9	4.2	0.0	0.0	0.0	5.4	0.0	0.8	3.2	4.7	0.1	0.5	0.0	0.0	0.3
GAD2	GAD65	ENSG00000136750	"Glutamate decarboxylase 2"	Q05329	10	26216307-26304558	"Enzymes, Predicted intracellular proteins"	"Neurotransmitter biosynthesis"	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 66.2"	"Cell type enriched"	"Detected in some"	11	"Pancreatic endocrine cells: 35.1"	"Group enriched"	"Detected in some"	21	"glioma: 0.7;pancreatic cancer: 3.0;testis cancer: 1.2"	"Region enhanced"	"Detected in all"		"basal ganglia: 66.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"MOLT-4: 5.2;SCLC-21H: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044637, CAB078177"	Enhanced					NA	NA					"CAB078177: AB_2665779, HPA044637: AB_10794053"		"unprognostic (8.67e-2)"			"unprognostic (1.11e-1)"						"unprognostic (4.93e-2)"		"unprognostic (2.52e-5)"	"unprognostic (5.44e-2)"	"unprognostic (8.08e-2)"			1.0	0.9	6.3	0.9	66.2	1.0	0.9	5.6	28.7	0.9	0.9	1.4	0.0	1.2	0.9	1.1	0.9	0.9	0.9	0.9	5.2	13.2	1.0	0.9	0.9	0.9	5.4	10.0	0.9	12.9	0.9	0.4	0.9	6.8	1.2	1.0	0.0	0.9	0.9	0.9	1.3	1.1	0.9	1.3	0.9	1.2	1.7	8.1	0.0	0.9	0.0	0.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	6.3	66.2	5.6	18.2	5.2	13.2	5.4	10.0	6.8	8.1	0.0	0.0	0.0	0.0	0.0	2.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	3.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	35.1	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0
HADHA	"GBP, LCEH, LCHAD, MTPA"	ENSG00000084754	"Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha"	P40939	2	26190635-26244726	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Lyase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015536, HPA056070"	Approved		Enhanced	Mitochondria		NA	NA		2700000	Mitochondria		"HPA015536: AB_1850473, HPA056070: AB_2683026"	"unprognostic (2.02e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.67e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.16e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.81e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (3.68e-5)"	"unprognostic (7.97e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.87e-3)"	"unprognostic (2.64e-2)"	41.6	35.3	18.1	13.1	19.5	17.0	23.9	17.4	16.9	20.2	44.9	26.5	15.7	48.1	21.1	15.3	30.8	20.5	15.1	80.0	15.6	15.5	41.3	71.7	17.7	19.3	21.6	13.1	27.3	37.5	29.8	23.5	21.3	24.8	21.9	32.2	23.6	21.1	16.6	117.5	23.3	66.4	25.1	27.8	24.0	24.1	18.7	19.0	25.2	25.1	41.3	24.6	26.9	18.8	15.3	28.9	12.4	32.2	13.5	17.6	26.0	23.6	21.1	13.9	22.7	55.2	34.5	11.8	18.5	20.0	19.1	16.6	26.6	23.0	15.6	12.2	32.6	19.7	15.1	24.3	35.9	17.3	35.0	29.8	23.4	22.4	44.3	19.0	29.4	17.2	35.3	23.6	27.1	27.3	20.0	32.0	16.8	31.8	31.7	24.6	29.0	12.8	33.0	11.9	17.8	40.7	11.9	30.0	33.5	21.9	28.5	9.8	19.5	21.8	22.7	25.1	11.3	12.1	28.6	29.3	11.1	16.5	16.7	13.6	10.4	20.6	27.8	17.4	34.9	13.4	8.1	27.7	12.4	12.3	32.2	14.8	15.3	14.2	15.0	28.9	11.2	16.7	15.3	7.4	13.5	28.0	11.0	17.6	26.0	18.1	19.5	17.4	16.9	15.6	15.5	21.6	13.1	24.8	19.0	83.4	81.9	90.4	122.8	79.0	34.1	285.8	71.4	101.7	126.3	73.3	49.1	149.8	111.0	102.7	26.5	92.1	406.5	23.3	94.5	78.0	88.0	61.7	134.2	168.3	142.3	19.1	87.7	68.7	130.6	58.2	85.7	124.9	77.6	129.0	139.2	61.8	86.9	196.4	79.2	150.1	61.9	51.8	104.9	121.4	35.2	90.3	108.0	105.4	168.5	92.1
HIBCH		ENSG00000198130	"3-hydroxyisobutyryl-CoA hydrolase"	Q6NVY1	2	190189735-190344193	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Branched-chain amino acid catabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Proximal tubular cells: 262.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036540, HPA036541, HPA067080"	Enhanced		Enhanced	Mitochondria		NA	NA		90000	Mitochondria		"HPA036540: AB_10673355, HPA036541: AB_2675182, HPA067080: "	"unprognostic (3.60e-3)"	"unprognostic (3.88e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.36e-3)"	"unprognostic (3.38e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.88e-1)"	"prognostic favorable (1.22e-4)"	"unprognostic (7.32e-2)"	"unprognostic (1.37e-2)"	"prognostic favorable (1.04e-10)"	"unprognostic (1.34e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.18e-3)"	13.7	38.6	18.1	10.1	19.5	5.0	15.8	16.4	18.7	16.3	15.8	14.5	13.0	24.7	17.0	13.0	20.2	10.2	10.0	13.7	18.5	12.7	65.7	56.8	7.6	8.2	20.1	10.8	9.5	29.5	35.8	24.7	7.8	21.0	11.7	18.7	15.0	10.6	12.2	17.5	23.7	16.5	11.3	18.2	9.0	10.4	10.6	22.2	10.5	17.4	15.4	9.3	12.5	49.2	24.2	15.1	14.6	7.6	17.3	20.0	7.3	9.8	7.6	16.3	10.3	15.4	13.6	9.0	10.7	5.7	10.1	11.0	23.5	8.7	15.0	15.3	9.2	7.2	18.9	17.2	14.7	15.3	21.5	13.4	20.0	15.9	20.5	5.2	14.2	7.4	11.0	7.9	11.8	2.1	14.8	16.3	14.3	24.2	13.1	11.0	9.1	14.5	16.4	5.1	13.4	15.5	18.0	11.7	38.0	22.8	29.9	12.4	11.7	9.2	13.2	30.2	24.8	14.9	11.1	11.5	10.7	10.0	7.2	7.5	8.4	17.8	12.5	9.7	12.4	8.4	12.9	6.7	14.6	11.9	7.6	12.8	24.2	13.3	12.5	11.1	18.7	14.2	18.2	3.5	17.3	5.7	15.1	20.0	7.3	18.1	19.5	16.4	18.7	18.5	12.7	20.1	10.8	21.0	22.2	20.8	19.6	31.1	98.9	49.7	35.7	23.4	40.8	28.1	28.4	34.9	96.2	40.5	97.8	21.8	145.2	29.2	35.8	0.0	25.6	16.9	26.6	30.4	10.3	97.2	29.6	23.8	36.2	76.7	17.4	44.8	32.2	15.7	43.9	14.4	25.9	37.9	16.2	17.3	42.8	262.7	51.0	38.8	26.4	17.5	27.2	35.5	16.7	21.3	53.3	81.2
SMOX	"C20orf16, dJ779E11.1, FLJ20746, MGC1010, PAO, PAOh1, SMO"	ENSG00000088826	"Spermine oxidase"	Q9NWM0	20	4120980-4187747	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Ductal cells: 48.0;Pancreatic endocrine cells: 84.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 2.1;neutrophil: 3.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 35.5;Karpas-707: 60.7;RPTEC TERT1: 28.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047117, HPA060198"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"		NA	NA			Nucleoplasm	"Nuclear membrane, Vesicles, Cytosol"	"HPA047117: AB_2679940, HPA060198: AB_2684220"	"unprognostic (1.24e-2)"	"unprognostic (6.55e-2)"	"unprognostic (7.24e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (3.33e-6)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (4.92e-2)"	"unprognostic (3.37e-1)"	"unprognostic (7.18e-2)"	"unprognostic (7.58e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (4.08e-2)"	"unprognostic (2.64e-3)"	"unprognostic (1.26e-2)"	"unprognostic (3.07e-1)"	3.5	3.1	26.0	4.1	22.7	24.2	3.4	10.1	29.0	9.6	6.7	23.5	17.6	9.5	10.2	6.9	6.1	4.7	14.0	2.9	28.8	16.2	3.8	4.4	2.1	4.0	25.1	16.5	9.2	28.9	8.7	6.0	5.7	20.7	8.1	1.4	6.5	10.6	10.2	2.5	7.8	7.1	3.9	25.9	2.9	7.4	3.9	24.1	0.3	3.9	3.4	2.6	5.3	5.2	0.1	2.1	3.5	0.9	0.2	0.2	15.3	3.2	35.5	2.5	1.8	1.7	2.6	4.5	4.6	8.9	3.4	2.3	14.6	8.9	0.0	1.5	4.2	5.5	6.5	2.0	2.2	1.4	0.0	1.1	6.2	1.1	14.8	10.9	1.2	2.5	9.8	4.0	7.1	3.0	4.1	6.0	5.0	1.3	60.7	2.0	1.0	2.3	3.5	3.1	3.1	4.9	2.0	3.1	8.4	28.0	2.4	0.5	2.1	8.6	1.0	15.9	1.3	0.1	1.5	7.1	3.9	3.7	0.7	3.6	2.8	0.4	0.0	3.2	1.5	3.0	0.0	0.9	0.1	0.0	0.4	0.0	0.1	0.2	0.2	2.1	0.0	0.0	0.0	3.5	0.2	0.1	1.0	0.0	15.3	26.0	22.7	10.1	17.6	28.8	16.2	25.1	16.5	20.7	24.1	0.0	0.3	1.5	9.5	11.2	0.5	1.4	12.7	1.4	4.5	10.4	0.0	0.3	0.0	48.0	3.1	5.6	2.1	23.3	26.4	0.6	9.5	12.1	5.7	2.0	16.2	0.0	5.8	14.1	3.4	5.6	13.6	10.4	8.5	36.9	2.1	28.2	84.5	0.8	12.7	1.4	1.3	0.0	8.1	4.2	4.9	9.3	0.2	0.0	2.9	8.8
UPB1	BUP1	ENSG00000100024	"Beta-ureidopropionase 1"	Q9UBR1	22	24494107-24528390	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 85.7"	"Group enriched"	"Detected in many"	7	"Hepatocytes: 119.4;monocytes: 36.9;Proximal tubular cells: 58.6"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 25.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	27	"basophil: 11.4;neutrophil: 3.0"	"Lineage enriched"	"Detected in single"	43	"granulocytes: 11.4"	"Group enriched"	"Detected in some"	5	"CACO-2: 11.2;NB-4: 4.6;THP-1: 6.1;U-937: 6.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA000728, HPA076321"	Enhanced					NA	NA		790000			"HPA000728: AB_1080471, HPA076321: "	"unprognostic (7.27e-2)"	"unprognostic (4.57e-3)"	"unprognostic (2.27e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.09e-4)"	"prognostic favorable (2.30e-7)"	"unprognostic (8.41e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.93e-1)"	"unprognostic (4.89e-6)"	"unprognostic (3.82e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.63e-3)"	0.1	0.0	0.1	0.1	0.2	1.0	0.1	0.1	0.1	0.1	1.1	0.1	0.1	0.6	0.1	0.5	0.1	0.0	0.1	0.5	0.1	0.0	13.5	85.7	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.2	0.2	1.5	0.1	0.1	0.2	0.0	0.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	11.4	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.2	0.0	0.0	11.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	1.2	0.0	0.3	1.2	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	4.6	0.0	0.2	0.0	0.1	0.4	0.3	0.1	0.0	0.2	1.1	1.3	0.4	0.0	0.0	0.0	6.1	0.5	0.1	0.1	0.0	0.0	1.2	0.1	1.3	1.4	6.9	0.0	11.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	3.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	1.3	0.0	1.2	0.6	3.0	1.8	0.0	0.0	0.0	1.8	9.8	0.1	10.0	0.1	0.8	2.3	0.0	0.0	0.3	0.1	1.0	1.0	0.0	119.4	0.1	0.0	2.4	4.9	3.7	0.9	0.3	0.0	0.0	36.9	0.0	0.3	0.0	0.0	0.0	58.6	2.0	0.0	2.1	3.4	6.4	1.0	0.2	0.0	0.0	0.7
